We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck to Appeal Vioxx Decision; Liability Could Reach $50 Billion, Analyst Says
Merck to Appeal Vioxx Decision; Liability Could Reach $50 Billion, Analyst Says
August 26, 2005
Embattled drugmaker Merck has vowed a steadfast legal defense of its once-lucrative pain drug Vioxx despite a recent stinging defeat in the first liability case to go to trial.